UniProt ID | ZN257_HUMAN | |
---|---|---|
UniProt AC | Q9Y2Q1 | |
Protein Name | Zinc finger protein 257 | |
Gene Name | ZNF257 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 563 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in transcriptional regulation.. | |
Protein Sequence | MGPLTIRDVTVEFSLEEWHCLDTAQQNLYRDVMLENYRNLVFLGIAVSKPDLITCLEQGKEPCNMKRHEMVAKPPVMCSHIAEDLCPERDIKYFFQKVILRRYDKCEHENLQLRKGCKSVDECKVCKGGYNGLNQCLITTQSKMYQCDKYVKVFYKFSNSDRHKIRHTEKKTCKCKECGKSFCMLSQLTRHKRIHIRENSHKCEECGKAFNQSSALTRHKMTHTGEKPYKCEECGKAFNRSSHLTQHKVIHTREKPYKCEECGKAFNRSSHITQHKRIHNREKPFKYDECCKAFKWSSALTTLTQHKRIHTGEKPYKCEECGKAFNQSSALTRHKMIHTGEKPFQCEECGKAFNRSSHLTQHKIIHTKEKPYKCEECGKAFNRSSHLTKHKRIHTREKAYKCDEYCKAFNWSSALTTLTQHKIIHTGEKPYKCEECGKAFNRSSYLIRHKIIHTGEKPYKCEECGKAFNQSSHLTQHKIIHTGEKPYKCEECGKAFNRSSHLSQHKIIHTGEKPYKCEECGKPFNRFSYLTVHKRIHAGENPNKYEECGKACNHSSNLTKHNS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
160 | Ubiquitination | VFYKFSNSDRHKIRH EEEECCCCCHHHCCC | 34.52 | 22505724 | |
188 | Ubiquitination | SFCMLSQLTRHKRIH HHHHHHHHHHCCCEE | 4.00 | 22505724 | |
204 | Ubiquitination | RENSHKCEECGKAFN CCCCCCHHHHHHHHH | 62.21 | 22505724 | |
222 | Phosphorylation | ALTRHKMTHTGEKPY HHHHCCCCCCCCCCC | 22.53 | 28348404 | |
224 | Phosphorylation | TRHKMTHTGEKPYKC HHCCCCCCCCCCCCC | 37.56 | 29083192 | |
227 | Ubiquitination | KMTHTGEKPYKCEEC CCCCCCCCCCCCHHH | 55.80 | - | |
229 | Phosphorylation | THTGEKPYKCEECGK CCCCCCCCCCHHHHH | 39.06 | - | |
230 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHHHC | 43.63 | - | |
230 | Ubiquitination | HTGEKPYKCEECGKA CCCCCCCCCHHHHHC | 43.63 | - | |
230 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCCHHHHHC | 43.63 | - | |
232 | Ubiquitination | GEKPYKCEECGKAFN CCCCCCCHHHHHCCC | 52.77 | 22505724 | |
236 | Ubiquitination | YKCEECGKAFNRSSH CCCHHHHHCCCCCCC | 62.56 | 22505724 | |
258 | Sumoylation | HTREKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
258 | Ubiquitination | HTREKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
258 | Sumoylation | HTREKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
264 | Ubiquitination | YKCEECGKAFNRSSH CCCHHHHHHCCCCCC | 62.56 | 22505724 | |
275 | Ubiquitination | RSSHITQHKRIHNRE CCCCHHHCCHHCCCC | 16.83 | 22505724 | |
297 | Phosphorylation | CCKAFKWSSALTTLT HHHHHCHHHHHHHHH | 13.31 | 26074081 | |
298 | Phosphorylation | CKAFKWSSALTTLTQ HHHHCHHHHHHHHHC | 26.61 | 26074081 | |
301 | Phosphorylation | FKWSSALTTLTQHKR HCHHHHHHHHHCCCC | 21.34 | 26074081 | |
302 | Phosphorylation | KWSSALTTLTQHKRI CHHHHHHHHHCCCCC | 28.76 | 26074081 | |
303 | Ubiquitination | WSSALTTLTQHKRIH HHHHHHHHHCCCCCC | 3.50 | 22505724 | |
304 | Phosphorylation | SSALTTLTQHKRIHT HHHHHHHHCCCCCCC | 26.91 | 26074081 | |
311 | Phosphorylation | TQHKRIHTGEKPYKC HCCCCCCCCCCCCCH | 44.67 | 29496963 | |
314 | Ubiquitination | KRIHTGEKPYKCEEC CCCCCCCCCCCHHHH | 55.80 | - | |
316 | Phosphorylation | IHTGEKPYKCEECGK CCCCCCCCCHHHHHH | 39.06 | - | |
317 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCHHHHHHH | 43.63 | - | |
317 | Ubiquitination | HTGEKPYKCEECGKA CCCCCCCCHHHHHHH | 43.63 | - | |
317 | Sumoylation | HTGEKPYKCEECGKA CCCCCCCCHHHHHHH | 43.63 | - | |
319 | Ubiquitination | GEKPYKCEECGKAFN CCCCCCHHHHHHHCC | 52.77 | 22505724 | |
339 | Phosphorylation | TRHKMIHTGEKPFQC HHCCCCCCCCCCCCC | 35.79 | 20068231 | |
347 | Ubiquitination | GEKPFQCEECGKAFN CCCCCCCHHHHHCCC | 45.60 | 22505724 | |
351 | Ubiquitination | FQCEECGKAFNRSSH CCCHHHHHCCCCCCC | 62.56 | 22505724 | |
362 | Ubiquitination | RSSHLTQHKIIHTKE CCCCCCCCCEEECCC | 20.32 | 22505724 | |
373 | Ubiquitination | HTKEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
373 | Sumoylation | HTKEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
373 | Sumoylation | HTKEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
379 | Ubiquitination | YKCEECGKAFNRSSH CCCHHHHHHCCCCHH | 62.56 | 22505724 | |
406 | Ubiquitination | AYKCDEYCKAFNWSS HHCHHHHHHHCCHHH | 2.11 | 22505724 | |
412 | Phosphorylation | YCKAFNWSSALTTLT HHHHCCHHHHHHHHH | 13.56 | 26074081 | |
413 | Phosphorylation | CKAFNWSSALTTLTQ HHHCCHHHHHHHHHH | 20.93 | 26074081 | |
416 | Phosphorylation | FNWSSALTTLTQHKI CCHHHHHHHHHHCCE | 21.34 | 26074081 | |
417 | Phosphorylation | NWSSALTTLTQHKII CHHHHHHHHHHCCEE | 28.76 | 26074081 | |
418 | Ubiquitination | WSSALTTLTQHKIIH HHHHHHHHHHCCEEE | 3.50 | 22505724 | |
419 | Phosphorylation | SSALTTLTQHKIIHT HHHHHHHHHCCEEEC | 26.91 | 26074081 | |
422 | Ubiquitination | LTTLTQHKIIHTGEK HHHHHHCCEEECCCC | 33.27 | - | |
426 | Phosphorylation | TQHKIIHTGEKPYKC HHCCEEECCCCCCCC | 36.31 | 29496963 | |
429 | Ubiquitination | KIIHTGEKPYKCEEC CEEECCCCCCCCHHH | 55.80 | - | |
431 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCCCCHHHHH | 39.06 | - | |
432 | Sumoylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | - | |
432 | Acetylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | 19825895 | |
432 | Sumoylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | - | |
432 | Ubiquitination | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | - | |
438 | Ubiquitination | YKCEECGKAFNRSSY CCCHHHHHCCCCCHH | 62.56 | 22505724 | |
450 | Ubiquitination | SSYLIRHKIIHTGEK CHHHHEEEEEECCCC | 33.24 | - | |
454 | Phosphorylation | IRHKIIHTGEKPYKC HEEEEEECCCCCCCC | 36.31 | 29496963 | |
457 | Ubiquitination | KIIHTGEKPYKCEEC EEEECCCCCCCCHHH | 55.80 | - | |
459 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCCCCHHHHH | 39.06 | - | |
460 | Sumoylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
460 | Sumoylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
460 | Acetylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | 19825901 | |
460 | Ubiquitination | HTGEKPYKCEECGKA ECCCCCCCCHHHHHH | 43.63 | - | |
462 | Ubiquitination | GEKPYKCEECGKAFN CCCCCCCHHHHHHHC | 52.77 | 22505724 | |
478 | Ubiquitination | SSHLTQHKIIHTGEK CCCCCCCCEEECCCC | 33.27 | - | |
482 | Phosphorylation | TQHKIIHTGEKPYKC CCCCEEECCCCCCCC | 36.31 | 29496963 | |
485 | Ubiquitination | KIIHTGEKPYKCEEC CEEECCCCCCCCHHH | 55.80 | - | |
487 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCCCCHHHHH | 39.06 | - | |
488 | Sumoylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | - | |
488 | Ubiquitination | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | - | |
488 | Sumoylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | - | |
488 | Acetylation | HTGEKPYKCEECGKA ECCCCCCCCHHHHHC | 43.63 | 19825907 | |
494 | Ubiquitination | YKCEECGKAFNRSSH CCCHHHHHCCCCCCC | 62.56 | 22505724 | |
506 | Ubiquitination | SSHLSQHKIIHTGEK CCCHHCCCEEECCCC | 35.40 | - | |
510 | Phosphorylation | SQHKIIHTGEKPYKC HCCCEEECCCCCEEC | 36.31 | 29496963 | |
513 | Ubiquitination | KIIHTGEKPYKCEEC CEEECCCCCEECCCC | 55.80 | - | |
515 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCEECCCCCC | 39.06 | - | |
516 | Sumoylation | HTGEKPYKCEECGKP ECCCCCEECCCCCCC | 43.63 | - | |
516 | Acetylation | HTGEKPYKCEECGKP ECCCCCEECCCCCCC | 43.63 | 19825913 | |
516 | Sumoylation | HTGEKPYKCEECGKP ECCCCCEECCCCCCC | 43.63 | - | |
516 | Ubiquitination | HTGEKPYKCEECGKP ECCCCCEECCCCCCC | 43.63 | - | |
531 | Phosphorylation | FNRFSYLTVHKRIHA CCCCEEEEECCCCCC | 16.60 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN257_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN257_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN257_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ZN257_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...